ePrivacy and GPDR Cookie Consent by TermsFeed Generator

IMATINIB GLENMARK

400MG TBL FLM 30

Announcement of launch, break or close-out of marketing of a medicinal product
Type of announcement Effective date Alternate medicines ? Reason for interruption/cessation of marketing Estimated renewal date
Cessation of marketing 28.05.2022 0209392, 0212649, 0028028, 0028386
Low determined reimbursement
Placing on the market 31.05.2017

All reports are available in the Overview.

Back to list